|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
New York University School of Medicine |
|---|---|
| Information provided by: | New York University School of Medicine |
| ClinicalTrials.gov Identifier: | NCT00212537 |
Purpose
Gene and protein bank to study disease modifying and susceptibility genes and proteins in urban patients with asthma.
| Condition |
|---|
|
Asthma |
| Study Type: | Observational |
| Study Design: | Natural History, Cross-Sectional, Case Control, Retrospective/Prospective Study |
| Official Title: | Disease Modifying Genes in Severe Asthma |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Joan Reibman, MD | 212-263-6479 | reibmj01@med.nyu.edu |
| United States, New York | |
| NYU School of Medicine | Recruiting |
| New York, New York, United States, 10016 | |
| Contact: Joan Reibman, MD 212-263-6479 reibmj01@med.nyu.edu | |
| Principal Investigator: Joan Reibman, MD | |
| Sub-Investigator: Linda Rogers, MD | |
| Principal Investigator: | Joan Reibman, MD | NYU School of Medicine |
More Information
| Study ID Numbers: | H9698 |
| Study First Received: | September 19, 2005 |
| Last Updated: | November 27, 2006 |
| ClinicalTrials.gov Identifier: | NCT00212537 |
| Health Authority: | United States: Institutional Review Board |
|
Asthma and normal |
|
Hypersensitivity Lung Diseases, Obstructive Respiratory Tract Diseases Lung Diseases |
Hypersensitivity, Immediate Asthma Respiratory Hypersensitivity |
|
Immune System Diseases Bronchial Diseases |
